Search

everythinglearnresearchcommunity

for

Search:↓

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Nanocomposite patches improve drug delivery through the skin, offering controlled release and fewer side effects.

New methods may speed up drug development for male subfertility.

3D-oxy exosomes may significantly boost hair growth, offering new treatment options for hair loss.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Cancer treatments often cause skin, nail, and hair problems.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Epidermal stem cells show promise for future dermatology treatments due to ongoing advancements.